Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Interest & Investment Income (2019 - 2025)

Silo Pharma's Interest & Investment Income history spans 6 years, with the latest figure at $44604.0 for Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 47.49% year-over-year to $44604.0; the TTM value through Sep 2025 reached $234355.0, down 34.64%, while the annual FY2024 figure was $333165.0, 16.4% down from the prior year.
  • Interest & Investment Income for Q3 2025 was $44604.0 at Silo Pharma, down from $44917.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $116178.0 in Q3 2023 and bottomed at $377.0 in Q2 2022.
  • The 4-year median for Interest & Investment Income is $77042.0 (2024), against an average of $73406.5.
  • The largest annual shift saw Interest & Investment Income surged 28967.37% in 2023 before it crashed 47.49% in 2025.
  • A 4-year view of Interest & Investment Income shows it stood at $70864.0 in 2022, then soared by 52.94% to $108380.0 in 2023, then decreased by 23.41% to $83006.0 in 2024, then crashed by 46.26% to $44604.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Interest & Investment Income are $44604.0 (Q3 2025), $44917.0 (Q2 2025), and $61828.0 (Q1 2025).